Stimulation of naive T cells results in their differentiation into effector cells with either a Th1 or Th2 phenotype. As Th1 cells develop, a number of genetic changes occur, including the loss of expression of IFN-γRβ chain ([@B1], [@B2]), the induced expression of a modified form of P-selectin glycoprotein ligand 1 ([@B3], [@B4]), and the priming for subsequent secretion of high levels of IFN-γ and TNF-β after T cell receptor stimulation ([@B5]). Similarly, as Th2 cells develop, there is a loss of expression of IL-12Rβ2 chain ([@B6], [@B7]), the induced expression of CCR3 ([@B8]), and the priming to secrete a different panel of cytokines after activation, including IL-4, IL-5, IL-10, and IL-13 ([@B5]).

Several lines of evidence have led to a paradigm of Th cell differentiation in which IL-12--mediated activation of signal transducer and activator of transcription (Stat)4 and IL-4--induced activation of Stat6 are critical for the generation of Th1 and Th2 cells, respectively. Mice harboring a disrupted gene for either IL-4 ([@B9], [@B10]), IL-4Rα ([@B11]), or Stat6 ([@B12]--[@B14]) fail to develop Th2 cells. Similarly, mice lacking either IL-12 ([@B15]), IL-12Rβ1 ([@B16]), or Stat4 ([@B17], [@B18]) demonstrate impaired Th1 cell function and, moreover, a propensity for T cells to develop into Th2 cells ([@B15], [@B17]).

Although these observations suggest that STAT proteins are important for the differentiation of Th cell subsets, they do not rule out the possibility that STAT-independent pathways may also exist. *Stat6^−/−^* lymphocytes are completely impaired in their ability to generate IL-4--secreting Th2 cells, suggesting that this differentiation pathway may be entirely dependent on Stat6. In contrast, reduced levels of IFN-γ are produced by *Stat4^−/−^* lymphocytes when cultured under conditions that promote Th1 cell differentiation, suggesting that Stat4 is not absolutely required for IFN-γ expression. Additionally, the cytokine environment during commitment to a Th cell lineage is clearly important, since IL-4 confers a dominant differentiation signal which inhibits Th1 cell differentiation even in the presence of IL-12 ([@B19]--[@B22]). These observations suggest that although the impaired development of Th1 cells in *Stat4^−/−^* mice may be due to the absence of Stat4, it may also be due in part to the preferential outgrowth of Th2 cells in response to IL-4--activated Stat6. Since IL-4 both activates Stat6 and interferes with the development of Th1 cells, we generated double-deficient mice lacking *Stat4* and *Stat6* to examine the ability of Th1 cells to develop in the absence of these two signaling molecules. Although lymphocytes lacking both *Stat4* and *Stat6* fail to differentiate into IL-4--secreting Th2 cells, they do give rise to functional IFN-γ--secreting Th1 cells both in vitro and in vivo.

Materials and Methods {#MaterialsMethods}
=====================

Mice.
-----

*Stat4*, *Stat6* ^−*/*−^ mice were generated by mating *Stat4* ^−*/*−^ and *Stat6* ^−*/*−^ mice at the third backcross generation to Balb/c and intercrossing the resulting compound heterozygotes. Controls were inbred BALB/c and 129/SvJ mice, both of which gave comparable results in each of the assays tested.

In Vitro Culture and Differentiation.
-------------------------------------

Differentiation of T cells and assay of cytokines were performed as described ([@B12], [@B17]). In brief, cells were activated with 1 μg/ml plate-bound anti-CD3. Where indicated, IL-12 was added at 1 ng/ml, and anti--IFN-γ, anti--IL-4, and anti--IL-12 were added at 10 μg/ml (Genzyme Corp., Cambridge, MA). After 1 wk in culture, cells were washed and restimulated with plate-bound anti-CD3 for 24 h. Supernatants were harvested, and IFN-γ and IL-4 production were quantified by ELISA. Purification of CD4^+^ and CD62L^+^ cells was done by positive selection using magnetic beads (Miltenyi Biotec, Inc., Auburn, CA) according to the supplier\'s instructions. CD4^+^ isolated cells were ∼90% CD4^+^. For the purification of naive cells, pooled spleens and lymph nodes were depleted before positive selection with 2.4G2 (anti-CD16/32), 2.43 (anti-CD8), and M5114 (anti--I-A^d^) coupled to magnetic beads.

Enzyme-linked Immunospot.
-------------------------

Cells were activated and cultured as above. After 1 wk, cells were restimulated with plate-bound anti-CD3 for 6 h and plated in dilution on anti--IFN-γ (R4/6A2)-coated Immobilon-P membranes in a 96-well plate for 18 h. Cells were washed away, and bound cytokine was detected with biotinylated anti--IFN-γ (PharMingen, San Diego, CA), avidin--alkaline phosphatase (Sigma Chemical Co., St. Louis, MO), and a stable BCIP/NBT mix (GIBCO BRL, Gaithersburg, MD). Spots were developed for 30--60 min, washed with distilled water, and counted under a dissecting microscope.

Delayed-type Hypersensitivity Reaction.
---------------------------------------

Male mice were immunized with 100 μg DNP-KLH (Calbiochem Corp., La Jolla, CA) emulsified in CFA (Sigma Chemical Co.), at the base of the tail. After 6 d, footpad thickness was measured using a spring-loaded caliper, and mice were challenged with 50 μg DNP-KLH in one foot and PBS in the contralateral appendage. Footpad thickness was measured blindly at 24 and 48 h after challenge. Specific swelling was determined by subtracting nonspecific swelling in the PBS-injected foot from antigen-induced swelling. At killing, popliteal and inguinal lymph nodes were removed and stimulated with 500 μg/ml DNP-KLH at a cell concentration of 10^6^/ml for IFN-γ production and 2 × 10^5^ for proliferation assay. Proliferation assays were pulsed with \[^3^H\]thymidine for the last 18 h of a 72-h incubation.

Results and Discussion {#ResultsDiscussion}
======================

To further examine the mechanism by which Stat4 and Stat6 regulate the differentiation of Th cell subsets, we generated *Stat4*, *Stat6* ^−*/*−^ mice by intercrossing compound heterozygotes. Double-deficient mice were produced at the expected mendelian frequency and were grossly indistinguishable from their control littermates. All lymphoid organs in *Stat4*, *Stat6* ^−*/*−^ mice had normal cellularity and contained percentages of CD3^+^, CD4^+^, CD8^+^, and B220^+^ cells comparable to that seen in control littermates (data not shown).

Spleen cells from control, *Stat4* ^−*/*−^, *Stat6* ^−*/*−^, and *Stat4*, *Stat6* ^−*/*−^ mice were activated in vitro with plate-bound anti-CD3 in the absence of exogenous cytokines or antibodies to determine their developmental potential. After 1 wk in culture, cells were washed and restimulated with plate-bound anti-CD3 for 24 h. Supernatants were harvested, and IFN-γ and IL-4 production were quantified by ELISA. As expected, lymphocytes from control mice secrete both IFN-γ and IL-4 when activated in vitro under neutral conditions (Fig. [1](#F1){ref-type="fig"}). Consistent with previous results ([@B12]--[@B14], [@B17], [@B18]), *Stat4* ^−*/*−^ lymphocytes produce high levels of IL-4 but greatly reduced levels of IFN-γ, whereas *Stat6* ^−*/*−^ lymphocytes secrete high levels of IFN-γ but no IL-4. *Stat4*, *Stat6* ^−*/*−^ lymphocytes also do not produce IL-4 when activated in vitro, supporting the notion that Stat6 is essential for the differentiation of Th2 cells. However, in contrast to *Stat4* ^−*/*−^ lymphocytes, *Stat4*, *Stat6* ^−*/*−^ lymphocytes secrete levels of IFN-γ comparable to that produced by control or *Stat6* ^−*/*−^ lymphocytes cultured under identical conditions. Similar results were seen when cultures were either initiated with purified naive T cells obtained by selection of CD4^+^ CD62L^+^ cells or when CD4^+^ T cells were purified after the initial 7-d culture period and subsequently restimulated with anti-CD3 for 24 h (data not shown).

IL-4 signaling has a dominant effect over IL-12 stimulation in determining the outcome of Th cell differentiation ([@B21]), and the results shown in Fig. [1](#F1){ref-type="fig"} suggest that the presence of IL-4 signaling through Stat6 may impair the ability of cells to develop the Th1 cell phenotype. To test this hypothesis, we attempted to recapitulate the IFN-γ--secreting phenotype of *Stat4*, *Stat6* ^−*/*−^ lymphocytes by activating Stat6-expressing cells in vitro in the presence of cytokine-specific antibodies to eliminate STAT activation. In the absence of exogenous cytokines and antibodies, in vitro--activated *Stat4*, *Stat6* ^−*/*−^ lymphocytes secrete more IFN-γ than *Stat4* ^−*/*−^ lymphocytes (Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} *A*). When *Stat4* ^−*/*−^ lymphocytes are activated in the presence of anti--IL-4, the levels of IFN-γ produced are nearly equal to those seen in cultures of activated *Stat4*, *Stat6* ^−*/*−^ lymphocytes (Fig. [2](#F2){ref-type="fig"} *A*). Similarly, when control cells are activated in the presence of anti--IL-4 plus anti--IL-12, the levels of IFN-γ produced are indistinguishable from those seen in cultures of activated *Stat4*, *Stat6* ^−*/*−^ lymphocytes. These results are consistent with a recent report demonstrating IFN-γ production in the presence of neutralizing antibodies to both IL-4 and IL-12 ([@B23]). Thus, substantial amounts of IFN-γ can be produced by activated cells lacking Stat4 as long as Stat6 is not activated in response to IL-4 stimulation.

IFN-γ has been suggested to have an important role in priming cells for subsequent IFN-γ production, although it remains controversial whether it does so by a direct or indirect mechanism. Inclusion of anti--IFN-γ to primary cultures of *Stat4*, *Stat6* ^−*/*−^ lymphocytes activated under neutral conditions did not affect the amount of IFN-γ produced by these cells after restimulation with anti-CD3 (Fig. [2](#F2){ref-type="fig"} *B*). This is in contrast to the lower amount of IFN-γ produced by control cells after restimulation when anti--IFN-γ was added in the primary culture. These results demonstrate that the ability of *Stat4*, *Stat6* ^−*/*−^ lymphocytes to acquire an IFN-γ--secreting phenotype is not driven by endogenous IFN-γ, and are consistent with studies demonstrating that the role of IFN-γ in Th1 cell differentiation is indirect, upregulating IL-12Rβ2 expression so that cells become responsive to IL-12 stimulation ([@B7]).

IL-12 stimulation of activated T cells has been shown to prime cells for high levels of IFN-γ production after subsequent restimulation ([@B24]). When compared with control lymphocytes cultured under Th1 cell--promoting conditions (IL-12 plus anti--IL-4), the levels of IFN-γ produced by activated *Stat4*, *Stat6* ^−*/*−^ lymphocytes were decreased four- to fivefold (Fig. [3](#F3){ref-type="fig"} *A*). The amount of IFN-γ produced by *Stat4*, *Stat6* ^−*/*−^ lymphocytes cultured in the presence of IL-12 does not increase over that seen when no exogenous cytokines are added (data not shown). The increased amounts of IFN-γ seen in cultures of Th1 cell--skewed control lymphocytes relative to those seen in cultures of *Stat4*, *Stat6* ^−*/*−^ lymphocytes could be the result of an increase either in the number of differentiated Th1 cells or in the amount of IFN-γ produced on a per cell basis. To distinguish between these possibilities, the number of IFN-γ--secreting lymphocytes in these cultures was quantified by enzyme-linked immunospot (ELISPOT). Spleen cells from control mice were differentiated into Th1 cells in vitro by activation with plate-bound anti-CD3 in the presence of IL-12 and anti--IL-4 while spleen cells from *Stat4* ^−*/*−^, *Stat6* ^−*/*−^, and *Stat4*, *Stat6* ^−*/*−^ mice were activated in the absence of exogenous cytokines and antibodies. After 1 wk in culture, CD4^+^ T cells were purified and restimulated with plate-bound anti-CD3 for 6 h. Cells were then transferred in dilution to plates containing anti--IFN-γ (R4/6A2)- coated Immobilon-P membranes at the bottom of the wells and incubated overnight. In contrast to cultures of *Stat4* ^−*/*−^ lymphocytes where very few IFN-γ--secreting cells were detected, large numbers were seen in cultures of Th1 cell-- skewed control and unskewed *Stat6* ^−*/*−^ lymphocytes (Fig. [3](#F3){ref-type="fig"} *B*). Strikingly, cultures of *Stat4*, *Stat6* ^−*/*−^ lymphocytes had numbers of IFN-γ--secreting cells comparable to that seen in cultures of Th1 cell--skewed control and unskewed *Stat6* ^−*/*−^ lymphocytes. The spots produced in wells containing Th1 cell--skewed control cells were both larger and darker than those seen in wells containing *Stat4*, *Stat6* ^−*/*−^ lymphocytes, supporting the conclusion that IL-12 stimulation and Stat4 activation lead to higher levels of IFN-γ production on a per cell basis rather than a substantial increase in the number of differentiated Th1 cells.

Given that IFN-γ--secreting cells could be generated from *Stat4*, *Stat6* ^−*/*−^ mice in vitro, we sought to determine whether *Stat4*, *Stat6* ^−*/*−^ mice could mount a Th1 cell response in vivo. To investigate this possibility, we examined a classic Th1 cell--mediated immune response, the delayed-type hypersensitivity (DTH) reaction. Control, *Stat4* ^−*/*−^, and *Stat4*, *Stat6* ^−*/*−^ mice were immunized with 100 μg DNP-KLH in CFA. 6 d later, mice were challenged by footpad injection with either aqueous antigen or PBS as control. All animals were killed 48 h after challenge, and draining popliteal and inguinal lymph node cells were removed and restimulated in vitro with antigen. Lymphocytes from all three genotypes of mice produced a similar in vitro proliferative response to antigen (Fig. [4](#F4){ref-type="fig"} *A*), demonstrating comparable in vivo generation of antigen-specific T cells. As expected, the levels of IFN-γ produced after antigen stimulation in vitro varied among the groups. *Stat4* ^−*/*−^ lymphocytes produced \<10% of the IFN-γ secreted by control cells (Fig. [4](#F4){ref-type="fig"} *B*). *Stat4*, *Stat6* ^−*/*−^ lymphocytes also secreted less IFN-γ than control cells, although the levels were fourfold higher than that seen in cultures of *Stat4* ^−*/*−^ lymphocytes (Fig. [4](#F4){ref-type="fig"} *B*). Finally, footpad thickness was measured before and 48 h after challenge, and specific swelling was calculated (Fig. [4](#F4){ref-type="fig"} *C*). Footpad swelling was significantly different in all three groups using the Kruskal-Wallis test (*P* \< 0.005). Furthermore, pairwise comparisons using the Wilcoxon-Mann-Whitney test showed that swelling in *Stat4* ^−*/*−^ mice was significantly reduced compared with control (*P* \< 0.005) and *Stat4*, *Stat6* ^−*/*−^ mice (*P* \< 0.05). Thus, functional Th1 cells capable of eliciting a DTH response can be generated in vivo in *Stat4*, *Stat6* ^−*/*−^ mice.

Our results demonstrate that the mechanisms that regulate the differentiation of Th1 and Th2 cells are not the same. Previous studies have shown that Stat6 is essential for the development of Th2 cells ([@B12]--[@B14]), presumably through the transcriptional regulation of as yet unidentified genes involved in the differentiation process. As IL-4--secreting Th2 cells are not generated from *Stat4*, *Stat6* ^−*/*−^ lymphocytes, Stat6 is required for their generation even in the absence of Stat4. In contrast, both Stat4-dependent and -independent pathways appear to exist for the development of IFN-γ--producing Th1 cells. IL-12 stimulation and Stat4 activation lead to the differentiation of Th1 cells capable of secreting large amounts of IFN-γ. However, in the absence of IL-4 and IL-12--mediated signals, the natural tendency of CD4^+^ Th cells is to develop into IFN-γ--secreting cells. Thus, IL-4--mediated activation of Stat6, but not IL-12-- induced activation of Stat4, results in a differentiative signal to Th cells. Mechanistically, this would explain the observation that IL-4 signaling has a dominant effect over IL-12 stimulation in determining the outcome of Th cell differentiation ([@B21]). Interestingly, a paradigm whereby the decision between two possible developmental pathways is dictated by the presence or absence of one signaling cascade occurs in other differentiative processes, including sex determination. *Sry* expression activates a genetic program which results in male gonadal development; female gonads develop in its absence ([@B25]).

Although our results suggest that the ability of IL-12 to promote Th1 differentiation may be indirect, by priming for high levels of IFN-γ production which would inhibit Th2 development and allow the outgrowth of Th1 cells, they do not minimize the role of IL-12 and Stat4 activation in normal Th cell development and function. Stat4 activation is clearly involved in regulating the production of IFN-γ and potentially other factors such as TNF-β that are important in many Th1 cell--mediated responses. Nevertheless, the demonstration that functional Th1 cells can develop in the absence of Stat4 has important implications for the design of therapeutic strategies that aim to alter immune function by targeting STAT proteins in vivo.
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![Th cell differentiation of STAT-deficient lymphocytes. Spleen cells from mice with the indicated genotypes were activated with plate-bound anti-CD3 in the absence of exogenous cytokines or antibodies for 1 wk. Supernatants were collected 24 h after restimulation with plate-bound anti-CD3, and cytokine levels were quantified by ELISA.](JEM980386.f1){#F1}

![IFN-γ production by STAT-deficient lymphocytes. (*A*) Spleen cells from mice with the indicated genotypes were activated with plate-bound anti-CD3 in the presence of antibodies as indicated for 1 wk. Cells were restimulated with plate-bound anti-CD3, and supernatants were collected 24 h later to quantify IFN-γ levels by ELISA. (*B*) Cells were activated as in *A* in the absence (*white bars*) or presence (*black bars*) of anti--IFN-γ. Cells were restimulated with plate-bound anti-CD3, and supernatants were collected 24 h later to quantify IFN-γ levels by ELISA.](JEM980386.f2){#F2}

![Quantification of IFN-γ--secreting cells. Spleen cells from mice with the indicated genotypes were activated with plate-bound anti-CD3 in the presence of exogenous cytokines or antibodies as indicated for 1 wk. (*A*) Cells were restimulated with plate-bound anti-CD3, and supernatants were collected 24 h later to quantify IFN-γ levels by ELISA. (*B*) Cells were restimulated with plate-bound anti-CD3 for 6 h and then transferred to plates containing anti--IFN-γ (R4/6A2)-coated membranes for 18 h. ELISPOTs were developed with a stable BCIP/NBT reagent and counted under a dissecting microscope. Th1-skewed control cultures had 750--1,000 IFN-γ--secreting cells/10^5^ CD4^+^ cells.](JEM980386.f3){#F3}

![DTH responses in STAT-deficient mice. (*A*) Draining lymph node cells from immunized mice were stimulated in vitro in the absence (*white bars*) or presence (*black bars*) of 500 μg/ml DNP-KLH. Cells in round-bottomed 96-well plates were pulsed with \[^3^H\]thymidine for the last 18 h of a 72-h incubation. (*B*) Supernatants from DNP-KLH-- stimulated lymph node cells were analyzed for IFN-γ levels by ELISA. (*C*) Specific footpad swelling of each mouse was determined by subtracting nonspecific swelling in the PBS-injected foot from the DNP-KLH-- induced swelling. Each data point represents one mouse; horizontal lines indicate averages, and results are pooled from two independent experiments.](JEM980386.f4){#F4}
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